Overview

  • Product nameIsradipine
  • Description
    L-type Ca2+ channel blocker
  • Biological descriptionL-type Ca2+ channel blocker.
  • Purity> 98%

Properties

    References for Isradipine (ab120142)

    This product has been referenced in:
    • Berjukow S  et al. Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem 275:22114-20 (2000). Read more (PubMed: 10766758) »
    • Zühlke RD  et al. Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human alpha1C subunit gene. FEBS Lett 427:220-4 (1998). Read more (PubMed: 9607315) »
    • Rüegg UT & Hof RP Pharmacology of the calcium antagonist isradipine. Drugs 40 Suppl 2:3-9 (1990). Read more (PubMed: 2150637) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120142.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"